Royalty Pharma (RPRX) Dividend Coverage Ratio (QoQ) (2019 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) Dividend Coverage Ratio (QoQ) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Incyte | 25.57 Bn | 21.04 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -79.94% |
| Mar 31, 2026 | 34.45% |
| Dec 31, 2025 | -32.61% |
| Sep 30, 2025 | 440.01% |
| Jun 30, 2025 | -70.27% |
| Mar 31, 2025 | -24.10% |
| Dec 31, 2024 | -59.10% |
| Sep 30, 2024 | 310.35% |
| Jun 30, 2024 | 4,846.00% |
| Mar 31, 2024 | -100.46% |
| Dec 31, 2023 | 647.03% |
| Sep 30, 2023 | -65.92% |
| Jun 30, 2023 | -24.51% |
| Mar 31, 2023 | 182.85% |
| Dec 31, 2022 | -422.43% |
| Sep 30, 2022 | -56.08% |
| Jun 30, 2022 | 250.20% |
| Mar 31, 2022 | 1,691.59% |
| Dec 31, 2021 | -113.19% |
| Sep 30, 2021 | -75.35% |